Social media has made the aesthetics industry visible to an audience that barely existed as consumers a decade ago. Gen Z patients — many in their late teens and early twenties — are now arriving at clinics asking about botox injections before a single line has formed. The clinical and business response to this shift is one of the defining ethical debates of the current era.
“Baby Botox” — the use of small doses of muscle-relaxing toxin as a preventative measure against frown lines, forehead lines, and crow’s feet — has a genuine clinical rationale. Repeated muscle contraction is one of the primary drivers of dynamic wrinkle formation. Intervening before those patterns are entrenched could, in theory, delay their development.
The clinical argument for early intervention
Proponents point to the logic of preventative medicine across all healthcare disciplines. We vaccinate before illness, apply sun screen before sun damage, and recommend skin care routines before visible ageing begins. Why should neuromodulators be categorically different? In skilled hands, a conservative dose of toxin in a 22-year-old who habitually furrows their brow may be genuinely prophylactic rather than cosmetic.
Clinics offering complementary routes — prescription-grade facials, collagen-boosting treatments, and hydra glow facials — can often address the same concerns without injectable treatment at all, making them a clinically appropriate first step for younger patients.
“Treating a 21-year-old isn’t inherently wrong. Treating one without a thorough consultation, clear informed consent, and a documented clinical need — that is.”
The ethical risks and business pressures
The problem lies not in the treatment itself but in the ecosystem that surrounds it. Gen Z patients are disproportionately influenced by filtered imagery and aesthetic trends — and a clinic that builds its business model around capturing this demographic faces an uncomfortable conflict of interest. Is the practitioner recommending toxin injections because they are clinically indicated, or because a 20-year-old with disposable income and a TikTok-driven anxiety about their gummy smile or pebbled chin walked through the door?
There are longer-term physiological questions too. Sustained use of neuromodulators from a young age may, over decades, alter muscle mass and facial structure in ways that are not yet fully understood. Patients seeking dissolving lip fillers or filler dissolving in their thirties after starting treatments young are a growing and telling clinical cohort.
A framework for responsible practice
The most defensible clinical and commercial position is a tiered one. For Gen Z patients, the default first consultation should lean toward non-injectable options: hydrating facials, skin boosters, exosomes, and bespoke hyaluronic acid products from a medical-grade skincare range. Profhilo skin remodelling and polynucleotides offer genuine skin quality improvement without the ethical complexity of neuromodulators in young faces.
If, following full counselling and a waiting period, injectable injectable treatments remain the patient’s informed, autonomous choice — and the clinical need is documented — then proceeding is defensible. What is not defensible is treating the demand as an uncomplicated revenue opportunity. The clinics navigating this best are those that lead with refusal where appropriate, and whose reputation is built on patients trusting them to say no as readily as yes.
